Atlas FDA

Sphere-9™ Mapping and Ablation Catheter

FDA premarket approval P240013/S010 · decided 2025-09-04

Approval details

PMA number
P240013
Supplement
S010
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Sphere-9™ Mapping and Ablation Catheter
Generic name
Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation
Applicant
Medtronic, Inc.
Date received
2025-06-06
Decision date
2025-09-04
Days to decision
90 days
Decision code
APPR
Product code
QZI
Advisory committee
Cardiovascular
Expedited review
No
Location
Mounds View, MN
Statement
approval for modifications to the catheter packaging

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19